GWMIA
AUPH icon

Global Wealth Management Investment Advisory’s Aurinia Pharmaceuticals AUPH Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$7K – 459
2020
Q3 		$7K Buy
+500
New +$7.24K ﹤0.01% 298

Other funds holding AUPH

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Global Wealth Management Investment Advisory's AUPH Position: Q4 2020 in Review

Global Wealth Management Investment Advisory sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2020, closing a stake of 500 shares — an estimated $7K sold.

Global Wealth Management Investment Advisory first reported a position in AUPH in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 145 funds tracked by Wall St. Rank hold AUPH as of Q4 2020.

  • Global Wealth Management Investment Advisory reported no remaining Aurinia Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 500 Aurinia Pharmaceuticals shares in Q4 2020, an estimated $7K.
  • Global Wealth Management Investment Advisory first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Global Wealth Management Investment Advisory's Aurinia Pharmaceuticals position peaked at $7K in Q3 2020.
  • 145 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q4 2020, filed 16 Feb 2021.